Results 1 to 5 of 15

Incentives and Benefits in the Context of Public Healthcare Tenders

Belgium - July 12 2019 The Federal Agency for Medicinal and Health Products ("FAMHP") recently published a circular (Circular No 646) in which it reminds hospitals that in…

Stef Feyen, Jens Mosselmans

Belgian Competition Authority Fines the Belgian Order of Pharmacists

Belgium - July 10 2019 In a decision of 28 May 2019, the Belgian Competition Authority ("BCA") imposed a fine of one million euros on the Belgian Order of Pharmacists…

Mauricette Schaufeli, Vincent Wellens

Transparency in Belgian Healthcare Relationships

Belgium - June 28 2019 recently released its second Sunshine Act publication, based on information provided by 596 pharma and medical device companies. In…

Jeroen Boelens, Florence Verhoestraete, Vincent Wellens

Belgium: New Measures to Tackle the Unavailability of Medicinal Products

Belgium - April 7 2019 The unavailability of certain medicines in Belgium is nothing new, and this situation is certainly not unique in Europe. However, with shortages of…

Florence Verhoestraete

European SPC Waiver for Export and Stockpiling of Generics and Biosimilars

European Union - March 27 2019 On 14 February 2019, the Committee of the Permanent Representatives of the Governments of the Member States (Coreper) endorsed a draft regulation…

Florence Verhoestraete, Anne Marie Verschuur, Vincent Wellens